Diality, Inc. (Irvine, CA, USA) is a Series-B stage, privately held medical device company with a mission to develop solutions that help improve the care and lives of patients with kidney disease. Our vision is a future where our technology enables all patients and partners to control kidney disease.
We are developing an extremely versatile hemodialysis solution that will allow more patients to benefit from their true dialysis prescription at home or in a variety of care settings, including nursing homes, hospitals and dialysis centers, without the need for pre-mixed dialysate bags or external water treatment.
The company was founded in 2015, and in 2018 Osman Khawar, MD expanded his role as Diality's Chief Medical Officer to become Chief Executive Officer. At that time the team's focus also expanded in response to the changing dynamics of the dialysis industry and the resulting need for hemodialysis technology that is versatile enough to accommodate emerging, innovative kidney-care models and the decentralization of dialysis delivery.